(1) Notwithstanding ORS 192.610 (Definitions for ORS 192.610 to 192.690) to 192.690 (Exceptions to ORS 192.610 to 192.690), the Pharmacy and Therapeutics Committee shall meet in an executive session for purposes of:
(a) Reviewing the prescribing or dispensing practices of individual physicians or pharmacists;
(b) Discussing drug use review data pertaining to individual physicians or pharmacists;
(c) Reviewing profiles of individual patients; or
(d) Reviewing confidential drug pricing information, including substantial cost differences between drugs within the same therapeutic class, that is necessary for the committee to make final recommendations under ORS 414.361 (Committee to advise and make recommendations on drug utilization review standards and interventions) or to comply with ORS 414.414 (Use and disclosure of confidential information).
(2) A meeting held in executive session is subject to the requirements of ORS 192.650 (Recording or written minutes required) (2). [2011 c.720 §10]
Note: See note under 414.351 (Definitions for ORS 414.351 to 414.414).
3 OregonLaws.org assembles these lists by analyzing references between Sections. Each listed item refers back to the current Section in its own text. The result reveals relationships in the code that may not have otherwise been apparent.